Antimitochondrial antibodies in patients with chronic hepatitis C

Liver

Volumn 16, Issue 3, 1996, Pages 161-165

  Grimbert, Sylvie ^a   Johanet, Catherine ^b   Bendjaballah, Fadila ^a   Homberg, Jean Claude ^b   Poupon, Raoul ^b   Beaugrand, Michel ^a  

^a HÔPITAL JEAN VERDIER   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Anti M2; Antimitochondrial antibodies; Chronic hepatitis C; Indirect immunofluorescence; Western blot

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; MITOCHONDRION ANTIBODY; OXIDOREDUCTASE; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; DISEASE COURSE; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE;

EID: 0029778734     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1996.tb00722.x     Document Type: Article

References (35)

1. ABUAF N, LUNEL F, GIRAL P, et al. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993: 18: 359-364.
2. PAWLOTSKY JM, BEN YAHIA M, ANDRE C, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994: 19: 841-848.
3. WILLEMS B, VILLENEUVE JP, FEINMAN SV, VINCELET J, POMIER-LAVRERQUES G. Autoantibodies anti-LKM and AMA during interferon treatment of chronic hepatitis C. J Hepatol 1991: 13: (Suppl 2): S 80.
4. HOMBERG JC. Anticorps anti tissue en hépatologie. Gastroenterol Clin Biol 1985. 9: 622-629.
5. BERG PA, KLEIN R. Heterogeneity of antimitochondrial antibodies. Semin Liver Dis 1989: 9: 103-116.
6. PROVENZANO G, DIQUATTRO O, CRAXI A, et al. Immunoblotting as a confirmatory test for antimitochondrial antibodies in primary biliary cirrhosis. Gut 1993. 34. 544-548.
7. KNODELL RG, ISHAK KG, BLACK WC, et al Formulation and application of a numerical scoring system for assessing activity in asymptomatic chronic active hepatitis. Hepatology 1981: 1: 431-435.
8. SCHEUER PJ, ASHRAFZADEH P, SHERLOCK S, BROWN D, DUSHEIKO GM. The pathology of hepatitis C. Hepatology 1992: 15: 567-571.
9. ROITT M, DONIACH D. Immunofluorescent tests for the detection of antibodies. In: Manuel des techniques immunologiques. Geneva: WHO, 1966.
10. DE DUVE C, PRESSMAN BC, GIANETTO R, WATTIAUX R, APPELMANS F. Tissue fractionation studies intracellular distribution patterns of enzymes in rat liver tissue. Biochem J 1955. 60. 604-610.
11. LAEMMLI UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1979: 227 680-685.
12. TOWBIN H, STAEHELIN T, GORDON J. Electrophoretic transfer of proteins from acrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979: 54: 731-738.
13. SOULIE E, MOULIN V, FOUREL V, DUBEL L, KANTARA-DOUKOURE M, JOHANET C. Caracterisation des anticorps antimitochondries de type 2 (anti-M2), comparaison de deux techniques, immunotransfert et immunofluorescence indirecte. Ann Biol Clin 1993 51: 707-711.
14. FERAY C, SAMUEL D, THIERS V, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992: 89: 4361-4365.
15. FUSSEY SP, GUEST JR, JAMES OF, BASSENDINE MF, YEAMAN SJ. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 1988 85: 8654-8658.
16. HOMBERG JC, LABRO MT. Anticorps anti-tissue non spécifiques d'organe en hépatologie. Feuill Biol 1977: 18: 41-457.
17. BRENARD R, DEGOS F, DEGOTT C, LASSOUED K, BENHAMOU JP. La cirrhose biliaire primitive: modes actuels de presentation. Gastrenterol Clin Biol 1990 14: 307-312.
18. HADDAD J, DENY P, MUNZ-GOTHEIL C, et al. Lymphocytic sialadenitis of Sjogren's syndrom associated with chronic hepatitis C virus liver disease. Lancet 1992: 339. 989-990.
19. SILVA M, LI X, CHEINQUER H, et al. HCV associated idiopathic thrombocytopenic purpura (ITP) (abst.). Gastroenterology 1992. 102: A 889.
20. PROTZER U, OCHSENDORF FR, LEOPOLDER-OCHSENDORF A, HOLTERMULLER KH; Exacerbation of lichen planus during interferon alfa-2a. Therapy for chronic active hepatitis C. Gastroenterology 1993. 104: 903-905.
21. PATERON D, HARTMANN DJ, DUCLOS-VALLÉE JC, JOUANOLLE H, BEAUGRAND M. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol 1992: 16: 244-245.
22. TADMOR B, PUTTERMAN C, NAPARSTEK Y. Embryonal germlayer antigens: target for autoimmunity. Lancet 1992: 339: 975-978.
23. BERTOLINI E, BATTEZZATI PM, ZERMIANI P, et al. Hepatitis C virus testing in primary biliary cirrhosis. J Hepatol 1992: 15. 207-210.
24. CHIEN RN, SHEEN IS, LIAW YF. Low prevalences of HBV and HCV infection in patients with primary cirrhosis in Taiwan. A case control study. J Gastroenterol Hepatol 1993 8. 574-576.
25. SCHRUMPF E, ELGJO K, FAUSA O, HAUKENES G, ROLLAG H. The significance of anti-HCV antibodies measured in chronic liver disease (abstract). J Hepatol 1990: 11: S111.
26. SHERLOCK S, SCHEUER PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973. 27: 674-678.
27. LEFKOWITCH JH, SCHIFF ER, DAVIS GL, et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology 1993: 104. 595-603.
28. VYBERG M. The hepatitis associated bile duct lesion. Liver 1993. 13. 289-301.
29. DUBEL L, FARGES O, BISMUTH H, HOMBERG JC, JOHANET C. Kinetic of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis. J Hepatol 1995: 23: 674-680.
30. DONALDSON PT, DOHERTY DG, HAYLLAR KM, MCFARLANE IG JOHNSON PJ, WILLIAMS R. Susceptibility to autoimmune chronic hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991: 13: 701-706.
31. CALMUS Y, GANE P, ROUGER P, POUPON R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990: 11: 12-15.
32. KLEIN R, WIEBEL M, ENGELHART S, BERG P A. Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Clin Exp Immunol 1993: 92: 308-316.
33. HOPF U, STEMEROWICZ R, RODLOFF A, et al. Relation between Escherichia coli R (rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet 1989: 2. 1419-1421.
34. BUTLER P, VALLE F, HAMILTON-MILLER JMT, BRUMFITT W, BAUM H, BURROUGHS AK. M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with recurrent bacteriuria. J Hepatol 1993: 17: 408-414.
35. RICHARDET JP, LONS T, JOHANET C, et al. Prévalence et caractéristiques des anticorps anti-tissue au cours des hépatites chroniques dues au virus de l'hépatite C. Gastraenterol Clin Biol 1994: 18: 819-823.